*Note: All information and materials provided has expired for CME credit possibilities and is solely to be used for informational purposes only.
The development of atherosclerosis is mediated by lipoproteins. This presentation will cover the role of lipoproteins in lipid metabolism, including which clinical markers are important to assess to determine cardiovascular risk.
Disclosures (at time of recording): Speaker:
Thomas Dayspring, MD, FACP, FNLA, NCMP: Health Diagnostic Lab: Consultant; GlaxoSmithKline: Lecture Bureau; Kowa Pharmaceuticals: Consultant
William McCarthy, MD, FOMA: Ridgetop Research: Offered Expert Opinion on Qsymia
Cookies are small pieces of information that are stored by your browser on your computer’s hard drive.
You can delete or block cookies within your browser settings.
Should you opt to do this, some parts of our site may not work.
For more information, including instructions on how to remove the cookies that have been placed,